z-logo
Premium
Mepyramine but not cimetidine or clobenpropit blocks pertussis toxin‐induced histamine sensitization in rats
Author(s) -
Vleeming W,
Hendriksen C F M,
Van De Kuil A,
Van Den Hout J W E,
De Wildt D J
Publication year - 2000
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0703263
Subject(s) - cimetidine , mepyramine , histamine , pertussis toxin , pharmacology , histamine h2 receptor , histaminergic , chemistry , histamine receptor , medicine , endocrinology , receptor , antagonist , g protein
The effects of pertussis toxin (PT) and the role of histaminergic H 1 , H 2 and H 3 receptor blockade on the actions of histamine on blood pressure, heart rate, blood gas values, and mortality were studied in anaesthetized rats. Four days after treatment with PT, histamine dose‐dependently decreased mean arterial blood pressure (MAP) and PT enhanced the histamine‐induced decrease in MAP. In the PT but not in the inactivated PT (IPT) or saline treated group three out of six animals died after the highest dose of histamine (300 mg kg −1 , i.v.) In order to determine the type of histamine receptor that mediates HS, 4 days after PT the selective antagonists mepyramine (H 1 ), cimetidine (H 2 ) and clobenpropit (H 3 ) were administered 20 min before the challenge with histamine. Mepyramine completely inhibited both the enhanced histamine‐induced decrease in MAP and mortality brought about by PT. Cimetidine and clobenpropit had no protective effects, but rather enhanced the histamine‐induced mortality elicited by PT. The present study shows that PT caused HS in rats which is primarily mediated via H 1 and secondarily via H 2 and H 3 receptors. These results are considered to be a first step in the elucidation of the mechanism(s) of the HS test used in the quality control of acellular pertussis vaccine.British Journal of Pharmacology (2000) 129 , 1801–1807; doi: 10.1038/sj.bjp.0703263

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here